KINI ROUNDUP | Here are key headlines you may have missed, in brief.
1. Home Minister Hamzah Zainuddin has ordered an investigation into the book “Rebirth: Reformasi, Resistance, and Hope in New Malaysia” for allegedly using the national coat of arms improperly. Others have lodged 21 police reports alleging that the book desecrates the emblem.
2. Langkawi MP Dr Mahathir Mohamad said the proposal to make his son Mukhriz Mahathir prime minister did not come from him, but was suggested by Pakatan Harapan leaders.
3. Sabah Chief Minister Mohd Shafie Apdal said he is grateful for the proposal to make him Pakatan Harapan’s choice to be the next prime minister, but he needs to consult his allies on the matter first.
4. Former PKR Women’s wing chief Haniza Talha said the party’s move to sack her was an “act of revenge”. PKR vice-president Tian Chua was sent a warning letter and he declined to comment on the matter, while Machap Jaya state assemblyperson Ginie Lim, who was also issued a warning letter, said she was innocent.
5. Former prime minister Najib Abdul Razak and other political leaders have urged the government to make public the findings of the independent inquiry into a 2016 fire at Sultanah Aminah Hospital, Johor Bahru, after a second fire broke out at the hospital over the weekend.
6. Amanah and DAP said they will reject any deal or any attempt to form a deal with Perikatan Nasional, after it was revealed that PKR president Anwar Ibrahim had met with Bersatu secretary-general Hamzah Zainuddin.
7. Former political secretary to Tengku Adnan Tengku Mansor, Mohd Rafi Alli Hassan, told the High Court in Kuala Lumpur that he received RM1,013,200 in cash from his boss for use in the 2016 Sungai Besar by-election.
8. Health Ministry director-general Dr Noor Hisham Abdullah has warned that enforcement action would be taken against those who are under home quarantine but fail to go for follow-up testing near the end of their quarantine period.
9. Health Minister Dr Adham Baba has announced that an RM2 million haemodialysis centre will be built in Chini.
10. Pharmaceutical company Gilead Sciences Inc has priced the Covid-19 drug candidate Remdesivir at US$2,340 (RM10,010.52) for a five-day treatment in some developed countries, although generic versions of the drug for 127 developing countries (not including Malaysia) will be much cheaper.